Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- National Cancer Institute (NCI)
- Study ID
- NCT00003368
- Phase
- PHASE1
- Status
- Completed
Conditions
- Lymphoma
- Small Intestine Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- irinotecan hydrochloride — DRUG
Study Details
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Irinotecan may be effective in treating patients with abnormal liver or kidney function or who have received radiation therapy. PURPOSE: Phase I trial to study the effectiveness of irinotecan in treating patients with solid tumors or lymphoma who have abnormal liver or kidney function or who have had previous radiation therapy to the pelvis.
Key Dates
- Start date
- Jun 30, 1998
- Status verified
- Jul 2006
- Completion
- Jul 31, 2006
Study Design
- Primary purpose
- TREATMENT
Locations (45)
Find similar trials in Birmingham, AL
By research site
Veterans Affairs Medical Center - Birmingham· Birmingham, ALUniversity of California San Diego Cancer Center· La Jolla, CAUCSF Cancer Center and Cancer Research Institute· San Francisco, CAVeterans Affairs Medical Center - San Francisco· San Francisco, CACCOP - Christiana Care Health Services· Wilmington, DEWalter Reed Army Medical Center· Washington D.C., DC
Related Studies
- Bone Marrow Grafting for Leukemia and LymphomaEnrolling By Invitation · Stanford University · Stanford, California
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative DisordersRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid TumorsRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerRecruiting · UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina